| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 5.23e-12 | 17 | 123 | 7 | GO:0005132 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH4 MYH13 DNAH10 MYO1H MYO1B MYO5C DNAH12 MYO15A DYNC1H1 | 3.02e-09 | 118 | 123 | 10 | GO:0003774 |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.05e-09 | 38 | 123 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH4 PDE1A MYH13 MYO1B SYT7 IQGAP1 MYO5C ASPM KCNQ3 MYO15A | 1.85e-07 | 230 | 123 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | actin filament binding | 1.45e-06 | 227 | 123 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 MYH13 MYO1H SPTA1 DYRK1A MYO1B ACTR2 IQGAP1 MYO5C SYNE2 PARVA DIAPH3 MYO15A | 1.53e-06 | 479 | 123 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH4 ATP8B4 MYH13 DNAH10 MYO1H MYO1B ZNFX1 MYO5C ORC1 DNAH12 DQX1 DDX60L MYO15A DYNC1H1 | 5.72e-06 | 614 | 123 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.20e-04 | 78 | 123 | 5 | GO:0003725 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH4 MYH13 MYO1H SPTA1 DYRK1A MYO1B ACTR2 IQGAP1 MYO5C FARP2 ALMS1 SYNE2 CLTC PARVA JAKMIP1 DIAPH3 MYO15A | 1.36e-04 | 1099 | 123 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | cytokine activity | 1.61e-04 | 250 | 123 | 8 | GO:0005125 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.74e-04 | 18 | 123 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | triacylglycerol lipase activity | 5.35e-04 | 26 | 123 | 3 | GO:0004806 | |
| GeneOntologyMolecularFunction | clathrin binding | 6.17e-04 | 63 | 123 | 4 | GO:0030276 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.68e-04 | 28 | 123 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 7.75e-04 | 7 | 123 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 9.03e-04 | 324 | 123 | 8 | GO:0005126 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.52e-03 | 37 | 123 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.77e-03 | 39 | 123 | 3 | GO:0070325 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 2.18e-11 | 21 | 121 | 7 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 6.39e-11 | 24 | 121 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 2.15e-10 | 28 | 121 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 4.57e-09 | 42 | 121 | 7 | GO:0002323 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 3.23e-08 | 55 | 121 | 7 | GO:0043330 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 8.46e-08 | 63 | 121 | 7 | GO:0043331 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 3.17e-07 | 112 | 121 | 8 | GO:0140888 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 6.79e-07 | 85 | 121 | 7 | GO:0060337 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 6.93e-07 | 124 | 121 | 8 | GO:0042100 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 7.35e-07 | 86 | 121 | 7 | GO:0071357 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 7.37e-07 | 125 | 121 | 8 | GO:0046425 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.00e-06 | 90 | 121 | 7 | GO:0098586 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.16e-06 | 92 | 121 | 7 | GO:0034340 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | SUCNR1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 ADORA3 KARS1 TLR4 LRP1 | 1.63e-06 | 365 | 121 | 12 | GO:0002263 |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.86e-06 | 63 | 121 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 2.04e-06 | 143 | 121 | 8 | GO:1904892 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 2.19e-06 | 101 | 121 | 7 | GO:0033138 | |
| GeneOntologyBiologicalProcess | defense response to virus | ZNFX1 ADARB1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 EPG5 DDX60L | 5.58e-06 | 342 | 121 | 11 | GO:0051607 |
| GeneOntologyBiologicalProcess | natural killer cell activation | 8.57e-06 | 124 | 121 | 7 | GO:0030101 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | SUCNR1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 ADORA3 KARS1 TLR4 | 9.29e-06 | 361 | 121 | 11 | GO:0002366 |
| GeneOntologyBiologicalProcess | microtubule-based process | DNAH10 DYRK1A BBS1 ACTR2 KAT2B CFAP54 DNAH12 ALMS1 CATSPER2 CCDC42 SYNE2 PRKAA2 CLTC ASPM ULK4 DIAPH3 GPSM1 DYNC1H1 PCM1 | 1.26e-05 | 1058 | 121 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.50e-05 | 90 | 121 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 1.64e-05 | 137 | 121 | 7 | GO:0033135 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 2.23e-05 | 198 | 121 | 8 | GO:0007259 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 2.71e-05 | 148 | 121 | 7 | GO:0002286 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.35e-05 | 153 | 121 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | organelle assembly | BBS1 SYT7 ACTR2 FARP2 DOCK5 KAT2B CFAP54 ALMS1 TBC1D10A CCDC42 SYNE2 PRKAA2 CLTC PARVA ASPM ULK4 DIAPH3 DYNC1H1 PCM1 | 3.46e-05 | 1138 | 121 | 19 | GO:0070925 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 4.15e-05 | 216 | 121 | 8 | GO:0097696 | |
| GeneOntologyBiologicalProcess | response to virus | ZNFX1 ADARB1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 EPG5 DDX60L | 4.18e-05 | 425 | 121 | 11 | GO:0009615 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 8.38e-05 | 307 | 121 | 9 | GO:0018105 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | DYRK1A BBS1 KAT2B ALMS1 CCDC42 SYNE2 PRKAA2 CLTC ASPM ULK4 DIAPH3 GPSM1 DYNC1H1 PCM1 | 8.45e-05 | 720 | 121 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.12e-04 | 319 | 121 | 9 | GO:0018209 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 1.19e-04 | 251 | 121 | 8 | GO:0002285 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | HTR2C PDK2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 STT3B IFNA17 EPG5 ITPR3 KAT2B PIK3CA PRKAA2 TLR4 LRP1 KCNQ3 TAAR1 | 1.51e-04 | 1272 | 121 | 19 | GO:1901698 |
| GeneOntologyBiologicalProcess | intracellular transport | SH3TC2 CLTCL1 ERO1B DYRK1A BBS1 SYT7 ACTR2 MYO5C EPG5 SEPTIN8 ALMS1 TBC1D10A SYNE2 CLTC LRP1 LRP2 KCNQ3 DIAPH3 DYNC1H1 PCM1 CCDC93 | 1.56e-04 | 1496 | 121 | 21 | GO:0046907 |
| GeneOntologyBiologicalProcess | B cell differentiation | 1.86e-04 | 201 | 121 | 7 | GO:0030183 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | ERO1B DYRK1A IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IQGAP1 IFNA17 CDC7 KAT2B IL20 VKORC1L1 PRKAA2 TLR4 | 1.88e-04 | 976 | 121 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | cilium assembly | BBS1 ACTR2 CFAP54 ALMS1 TBC1D10A CCDC42 SYNE2 PARVA ULK4 PCM1 | 2.91e-04 | 444 | 121 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH4 MYO1H SPTA1 MYO1B ACTR2 IQGAP1 MYO5C FARP2 ALMS1 PIK3CA SYNE2 PARVA LRP1 DIAPH3 MYO15A | 2.92e-04 | 912 | 121 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 3.37e-04 | 5 | 121 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 3.37e-04 | 5 | 121 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 3.39e-04 | 293 | 121 | 8 | GO:0032886 | |
| GeneOntologyBiologicalProcess | transcytosis | 3.64e-04 | 24 | 121 | 3 | GO:0045056 | |
| GeneOntologyBiologicalProcess | podosome assembly | 4.64e-04 | 26 | 121 | 3 | GO:0071800 | |
| GeneOntologyBiologicalProcess | cilium organization | BBS1 ACTR2 CFAP54 ALMS1 TBC1D10A CCDC42 SYNE2 PARVA ULK4 PCM1 | 5.03e-04 | 476 | 121 | 10 | GO:0044782 |
| GeneOntologyBiologicalProcess | immune effector process | SUCNR1 KMT2E IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 TWIST1 IFNA17 ADORA3 KARS1 TLR4 LRP1 | 5.15e-04 | 859 | 121 | 14 | GO:0002252 |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 5.16e-04 | 238 | 121 | 7 | GO:0050954 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 5.72e-04 | 398 | 121 | 9 | GO:0046651 | |
| GeneOntologyBiologicalProcess | endosomal transport | 6.07e-04 | 320 | 121 | 8 | GO:0016197 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | HTR2C IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IQGAP1 IFNA17 KAT2B PIK3CA IL20 PRKAA2 TLR4 | 6.46e-04 | 879 | 121 | 14 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | HTR2C IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IQGAP1 IFNA17 KAT2B PIK3CA IL20 PRKAA2 TLR4 | 6.46e-04 | 879 | 121 | 14 | GO:0010562 |
| GeneOntologyBiologicalProcess | spindle localization | 6.49e-04 | 67 | 121 | 4 | GO:0051653 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 6.59e-04 | 406 | 121 | 9 | GO:0032943 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DNAH10 BBS1 ACTR2 CFAP54 DNAH12 CATSPER2 SYNE2 ULK4 DYNC1H1 PCM1 | 6.59e-04 | 493 | 121 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 7.03e-04 | 7 | 121 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by transcytosis | 7.03e-04 | 7 | 121 | 2 | GO:0150093 | |
| GeneOntologyBiologicalProcess | response to X-ray | 7.12e-04 | 30 | 121 | 3 | GO:0010165 | |
| GeneOntologyBiologicalProcess | cell cycle process | SYCP2L KMT2E ACTR2 IQGAP1 CDC7 ORC1 SEPTIN8 KAT2B PPP2R5C ALMS1 CCDC42 CLTC ASPM ZFYVE26 DIAPH3 GPSM1 DYNC1H1 PCM1 CDC23 | 7.19e-04 | 1441 | 121 | 19 | GO:0022402 |
| GeneOntologyBiologicalProcess | cell division | ACTR2 IQGAP1 CDC7 SEPTIN8 KAT2B CLTC ASPM ULK4 ZFYVE26 DIAPH3 DYNC1H1 CDC23 | 8.20e-04 | 697 | 121 | 12 | GO:0051301 |
| GeneOntologyBiologicalProcess | actin filament organization | MYO1H SPTA1 MYO1B ACTR2 IQGAP1 MYO5C ALMS1 PIK3CA DIAPH3 MYO15A | 8.41e-04 | 509 | 121 | 10 | GO:0007015 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO1H SPTA1 MYO1B ACTR2 IQGAP1 MYO5C FARP2 ALMS1 PIK3CA PARVA LRP1 DIAPH3 MYO15A | 8.75e-04 | 803 | 121 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | cilium movement | 8.89e-04 | 261 | 121 | 7 | GO:0003341 | |
| GeneOntologyBiologicalProcess | B cell activation | 9.16e-04 | 341 | 121 | 8 | GO:0042113 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 1.03e-03 | 34 | 121 | 3 | GO:0090311 | |
| GeneOntologyBiologicalProcess | nuclear migration | 1.03e-03 | 34 | 121 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 1.12e-03 | 198 | 121 | 6 | GO:0007605 | |
| GeneOntologyCellularComponent | myosin complex | 5.44e-08 | 59 | 123 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 MYH13 MYO1H SPTA1 DYRK1A MYO1B ACTR2 IQGAP1 MYO5C DOCK5 KAT2B PARVA DIAPH3 MYO15A | 1.51e-06 | 576 | 123 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | muscle myosin complex | 1.05e-04 | 16 | 123 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 4.16e-04 | 25 | 123 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | protein phosphatase 4 complex | 5.07e-04 | 6 | 123 | 2 | GO:0030289 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.27e-04 | 238 | 123 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | myosin II complex | 5.85e-04 | 28 | 123 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | clathrin complex | 1.20e-03 | 9 | 123 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | motile cilium | 1.21e-03 | 355 | 123 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.28e-03 | 80 | 123 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.50e-03 | 10 | 123 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH4 MYH13 DNAH10 DYRK1A MYO1B IQGAP1 KAT2B DNAH12 SYNE2 CLTC PARVA ASPM JAKMIP1 DIAPH3 DYNC1H1 | 1.51e-03 | 1179 | 123 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH4 MYH13 DNAH10 DYRK1A MYO1B IQGAP1 KAT2B DNAH12 SYNE2 CLTC PARVA ASPM JAKMIP1 DIAPH3 DYNC1H1 | 1.62e-03 | 1187 | 123 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.68e-03 | 40 | 123 | 3 | GO:0005640 | |
| Domain | Interferon | 6.58e-12 | 17 | 119 | 7 | PF00143 | |
| Domain | INTERFERON_A_B_D | 6.58e-12 | 17 | 119 | 7 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 6.58e-12 | 17 | 119 | 7 | IPR000471 | |
| Domain | IFabd | 6.58e-12 | 17 | 119 | 7 | SM00076 | |
| Domain | - | 9.19e-10 | 50 | 119 | 8 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.08e-09 | 51 | 119 | 8 | IPR012351 | |
| Domain | Myosin-like_IQ_dom | 1.49e-09 | 19 | 119 | 6 | IPR027401 | |
| Domain | - | 1.49e-09 | 19 | 119 | 6 | 4.10.270.10 | |
| Domain | IQ | 1.63e-08 | 71 | 119 | 8 | PF00612 | |
| Domain | 4_helix_cytokine-like_core | 2.27e-08 | 74 | 119 | 8 | IPR009079 | |
| Domain | ARM-type_fold | PPP4R1 CLTCL1 NBEAL1 MROH2A ZNFX1 DOCK5 PPP2R5C PIK3CA CLTC ASPM ULK4 DIAPH3 BZW1 SYMPK | 3.42e-08 | 339 | 119 | 14 | IPR016024 |
| Domain | IQ | 4.67e-08 | 81 | 119 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.07e-07 | 90 | 119 | 8 | IPR000048 | |
| Domain | Myosin_head_motor_dom | 1.38e-07 | 38 | 119 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.38e-07 | 38 | 119 | 6 | PS51456 | |
| Domain | Myosin_head | 1.38e-07 | 38 | 119 | 6 | PF00063 | |
| Domain | MYSc | 1.38e-07 | 38 | 119 | 6 | SM00242 | |
| Domain | IQ | 1.39e-07 | 93 | 119 | 8 | PS50096 | |
| Domain | Myosin_N | 2.03e-06 | 15 | 119 | 4 | PF02736 | |
| Domain | Myosin_N | 2.03e-06 | 15 | 119 | 4 | IPR004009 | |
| Domain | Clathrin_H-chain_propeller_rpt | 4.03e-05 | 2 | 119 | 2 | IPR022365 | |
| Domain | Clathrin-link | 4.03e-05 | 2 | 119 | 2 | PF09268 | |
| Domain | - | 4.03e-05 | 2 | 119 | 2 | 2.130.10.110 | |
| Domain | Clathrin_heavy_chain | 4.03e-05 | 2 | 119 | 2 | IPR016341 | |
| Domain | Clathrin_H-chain_propeller_N | 4.03e-05 | 2 | 119 | 2 | IPR001473 | |
| Domain | Clathrin_H-chain_link/propller | 4.03e-05 | 2 | 119 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 4.03e-05 | 2 | 119 | 2 | PF01394 | |
| Domain | Clathrin_H-chain_linker_core | 4.03e-05 | 2 | 119 | 2 | IPR015348 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.72e-05 | 14 | 119 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 8.72e-05 | 14 | 119 | 3 | IPR013602 | |
| Domain | DHC_N2 | 8.72e-05 | 14 | 119 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 8.72e-05 | 14 | 119 | 3 | IPR011704 | |
| Domain | AAA_8 | 8.72e-05 | 14 | 119 | 3 | PF12780 | |
| Domain | AAA_5 | 8.72e-05 | 14 | 119 | 3 | PF07728 | |
| Domain | P-loop_NTPase | MYH1 MYH4 MYH13 DNAH10 MYO1B ZNFX1 IQGAP1 MYO5C ORC1 SEPTIN8 DNAH12 DQX1 ASPM DDX60L MYO15A DYNC1H1 | 9.54e-05 | 848 | 119 | 16 | IPR027417 |
| Domain | DHC_fam | 1.09e-04 | 15 | 119 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.09e-04 | 15 | 119 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.09e-04 | 15 | 119 | 3 | IPR004273 | |
| Domain | Clathrin_H-chain_linker | 1.20e-04 | 3 | 119 | 2 | IPR012331 | |
| Domain | CLH | 1.20e-04 | 3 | 119 | 2 | SM00299 | |
| Domain | TPR-like_helical_dom | 1.24e-04 | 233 | 119 | 8 | IPR011990 | |
| Domain | Myosin_tail_1 | 1.92e-04 | 18 | 119 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.92e-04 | 18 | 119 | 3 | IPR002928 | |
| Domain | - | 3.65e-04 | 207 | 119 | 7 | 1.25.40.10 | |
| Domain | CH | 7.86e-04 | 65 | 119 | 4 | SM00033 | |
| Domain | Clathrin | 8.28e-04 | 7 | 119 | 2 | PF00637 | |
| Domain | CHCR | 8.28e-04 | 7 | 119 | 2 | PS50236 | |
| Domain | CH | 1.04e-03 | 70 | 119 | 4 | PF00307 | |
| Domain | - | 1.10e-03 | 71 | 119 | 4 | 1.10.418.10 | |
| Domain | Clathrin_H-chain/VPS_repeat | 1.10e-03 | 8 | 119 | 2 | IPR000547 | |
| Domain | DHC_N1 | 1.10e-03 | 8 | 119 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.10e-03 | 8 | 119 | 2 | IPR013594 | |
| Domain | CH | 1.22e-03 | 73 | 119 | 4 | PS50021 | |
| Domain | CH-domain | 1.34e-03 | 75 | 119 | 4 | IPR001715 | |
| Domain | - | 1.95e-03 | 39 | 119 | 3 | 2.120.10.30 | |
| Domain | PNT | 2.13e-03 | 11 | 119 | 2 | PS51433 | |
| Domain | SAM_PNT | 2.13e-03 | 11 | 119 | 2 | PF02198 | |
| Domain | Pointed_dom | 2.13e-03 | 11 | 119 | 2 | IPR003118 | |
| Domain | SAM_PNT | 2.13e-03 | 11 | 119 | 2 | SM00251 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.14e-03 | 46 | 119 | 3 | IPR011042 | |
| Domain | - | 3.33e-03 | 47 | 119 | 3 | 3.30.420.10 | |
| Domain | Dynein_HC_stalk | 3.48e-03 | 14 | 119 | 2 | IPR024743 | |
| Domain | MT | 3.48e-03 | 14 | 119 | 2 | PF12777 | |
| Domain | Ldl_recept_b | 3.48e-03 | 14 | 119 | 2 | PF00058 | |
| Domain | LDLRB | 3.48e-03 | 14 | 119 | 2 | PS51120 | |
| Domain | LY | 4.00e-03 | 15 | 119 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.00e-03 | 15 | 119 | 2 | IPR000033 | |
| Domain | TPR_REGION | 4.12e-03 | 165 | 119 | 5 | PS50293 | |
| Domain | TPR | 4.12e-03 | 165 | 119 | 5 | PS50005 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 8.60e-12 | 17 | 94 | 7 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 1.40e-11 | 18 | 94 | 7 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 2.21e-11 | 19 | 94 | 7 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 3.37e-11 | 20 | 94 | 7 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 5.03e-11 | 21 | 94 | 7 | M47909 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 5.86e-11 | 35 | 94 | 8 | M6382 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 7.34e-11 | 22 | 94 | 7 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 7.34e-11 | 22 | 94 | 7 | M47616 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 9.51e-11 | 37 | 94 | 8 | M39785 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.05e-10 | 23 | 94 | 7 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 1.05e-10 | 23 | 94 | 7 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 1.47e-10 | 24 | 94 | 7 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 1.47e-10 | 24 | 94 | 7 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.47e-10 | 24 | 94 | 7 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 2.77e-10 | 26 | 94 | 7 | M982 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 8.39e-10 | 30 | 94 | 7 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.08e-09 | 31 | 94 | 7 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.08e-09 | 31 | 94 | 7 | M47964 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.89e-09 | 19 | 94 | 6 | MM1571 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.17e-09 | 34 | 94 | 7 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 2.70e-09 | 35 | 94 | 7 | M48246 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.71e-08 | 98 | 94 | 9 | M48247 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.43e-08 | 102 | 94 | 9 | M3261 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 2.50e-08 | 28 | 94 | 6 | MM1378 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 2.65e-08 | 103 | 94 | 9 | M39434 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 4.90e-08 | 52 | 94 | 7 | M13103 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 7.17e-08 | 33 | 94 | 6 | MM1379 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 7.31e-08 | 55 | 94 | 7 | M11844 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.01e-07 | 120 | 94 | 9 | M48233 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.10e-07 | 87 | 94 | 8 | MM15915 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 2.04e-07 | 39 | 94 | 6 | MM15914 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 2.38e-07 | 65 | 94 | 7 | M272 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.79e-07 | 41 | 94 | 6 | MM1493 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 2.95e-07 | 136 | 94 | 9 | M42547 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 4.39e-07 | 71 | 94 | 7 | M15913 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 5.32e-07 | 73 | 94 | 7 | M39837 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 7.16e-07 | 151 | 94 | 9 | M39801 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 8.40e-07 | 78 | 94 | 7 | M973 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 8.92e-07 | 155 | 94 | 9 | M17411 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.18e-06 | 82 | 94 | 7 | M1002 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | LAMC2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 LIPE PPP2R5C PIK3CA PRKAA2 | 1.67e-06 | 326 | 94 | 12 | MM15917 |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.91e-06 | 88 | 94 | 7 | M16004 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 2.02e-06 | 127 | 94 | 8 | M42533 | |
| Pathway | WP_PI3KAKT_SIGNALING | LAMC2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 PPP2R5C PIK3CA PRKAA2 TLR4 | 2.51e-06 | 339 | 94 | 12 | M39736 |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 3.57e-06 | 137 | 94 | 8 | M5669 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.75e-05 | 170 | 94 | 8 | M941 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 2.07e-05 | 126 | 94 | 7 | M45009 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 3.73e-05 | 138 | 94 | 7 | MM15635 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 3.77e-04 | 264 | 94 | 8 | M9809 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 4.24e-04 | 204 | 94 | 7 | M45011 | |
| Pathway | REACTOME_HEMOSTASIS | PDE1A DGKE IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 ITPR3 DOCK5 PPP2R5C PIK3CA | 5.50e-04 | 679 | 94 | 13 | M8395 |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 8.56e-04 | 299 | 94 | 8 | M41727 | |
| Pathway | PID_NECTIN_PATHWAY | 1.02e-03 | 30 | 94 | 3 | M72 | |
| Pathway | PID_CDC42_PATHWAY | 1.21e-03 | 70 | 94 | 4 | M81 | |
| Pubmed | 4.54e-15 | 12 | 123 | 7 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 4.54e-15 | 12 | 123 | 7 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 4.54e-15 | 12 | 123 | 7 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 4.54e-15 | 12 | 123 | 7 | 2572648 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 4.54e-15 | 12 | 123 | 7 | 7684767 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 4.54e-15 | 12 | 123 | 7 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 4.54e-15 | 12 | 123 | 7 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 4.54e-15 | 12 | 123 | 7 | 3758677 | |
| Pubmed | 4.54e-15 | 12 | 123 | 7 | 8245849 | ||
| Pubmed | 4.54e-15 | 12 | 123 | 7 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 4.54e-15 | 12 | 123 | 7 | 8760352 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 4.54e-15 | 12 | 123 | 7 | 7530016 | |
| Pubmed | 4.54e-15 | 12 | 123 | 7 | 9794206 | ||
| Pubmed | 4.54e-15 | 12 | 123 | 7 | 17451966 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 9.81e-15 | 13 | 123 | 7 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 9.81e-15 | 13 | 123 | 7 | 2014240 | |
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 18005734 | ||
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 9.81e-15 | 13 | 123 | 7 | 6094686 | |
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 1655578 | ||
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 2471809 | ||
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 8438572 | ||
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 9.81e-15 | 13 | 123 | 7 | 23255800 | |
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 7523540 | ||
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 9.81e-15 | 13 | 123 | 7 | 2987810 | |
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 19130550 | ||
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 22739040 | ||
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 9181467 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 9.81e-15 | 13 | 123 | 7 | 18726328 | |
| Pubmed | 9.81e-15 | 13 | 123 | 7 | 18572754 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 1.96e-14 | 14 | 123 | 7 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 1.96e-14 | 14 | 123 | 7 | 7526537 | |
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 19559726 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 15240719 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 16418394 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 18272764 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 11884139 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 19004943 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 1.96e-14 | 14 | 123 | 7 | 7532202 | |
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 1.96e-14 | 14 | 123 | 7 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 1.96e-14 | 14 | 123 | 7 | 17517919 | |
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 14983024 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 25972534 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 7583919 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 2987811 | ||
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 21172865 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 1.96e-14 | 14 | 123 | 7 | 15254193 | |
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 1.96e-14 | 14 | 123 | 7 | 1381203 | |
| Pubmed | 1.96e-14 | 14 | 123 | 7 | 8345204 | ||
| Pubmed | The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. | 2.88e-14 | 26 | 123 | 8 | 38744293 | |
| Pubmed | 3.66e-14 | 15 | 123 | 7 | 8786318 | ||
| Pubmed | 3.66e-14 | 15 | 123 | 7 | 15684736 | ||
| Pubmed | 3.66e-14 | 15 | 123 | 7 | 9520456 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 3.66e-14 | 15 | 123 | 7 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 3.66e-14 | 15 | 123 | 7 | 18339807 | |
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 3.66e-14 | 15 | 123 | 7 | 8661419 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 6.48e-14 | 16 | 123 | 7 | 22315404 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 6.48e-14 | 16 | 123 | 7 | 7904170 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 6.48e-14 | 16 | 123 | 7 | 18414664 | |
| Pubmed | 1.10e-13 | 17 | 123 | 7 | 22814248 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 1.10e-13 | 17 | 123 | 7 | 15233997 | |
| Pubmed | 1.79e-13 | 18 | 123 | 7 | 1905933 | ||
| Pubmed | 2.83e-13 | 19 | 123 | 7 | 7511078 | ||
| Pubmed | 2.83e-13 | 19 | 123 | 7 | 7815507 | ||
| Pubmed | 2.83e-13 | 19 | 123 | 7 | 17360657 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 2.83e-13 | 19 | 123 | 7 | 1708818 | |
| Pubmed | 2.83e-13 | 19 | 123 | 7 | 1385305 | ||
| Pubmed | 2.83e-13 | 19 | 123 | 7 | 17942529 | ||
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 4.34e-13 | 20 | 123 | 7 | 11694501 | |
| Pubmed | 4.34e-13 | 20 | 123 | 7 | 8764000 | ||
| Pubmed | 6.50e-13 | 21 | 123 | 7 | 9108403 | ||
| Pubmed | 7.88e-13 | 11 | 123 | 6 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 7.88e-13 | 11 | 123 | 6 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 7.88e-13 | 11 | 123 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 7.88e-13 | 11 | 123 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 7.88e-13 | 11 | 123 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 7.88e-13 | 11 | 123 | 6 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 7.88e-13 | 11 | 123 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 7.88e-13 | 11 | 123 | 6 | 15795237 | |
| Pubmed | 7.88e-13 | 11 | 123 | 6 | 9794439 | ||
| Pubmed | 7.88e-13 | 11 | 123 | 6 | 25310498 | ||
| Pubmed | 9.50e-13 | 22 | 123 | 7 | 7913356 | ||
| Pubmed | 9.50e-13 | 22 | 123 | 7 | 23100517 | ||
| Pubmed | 9.50e-13 | 22 | 123 | 7 | 16160188 | ||
| Pubmed | 1.36e-12 | 23 | 123 | 7 | 9225992 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.57e-12 | 12 | 123 | 6 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.57e-12 | 12 | 123 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.57e-12 | 12 | 123 | 6 | 27988795 | |
| Pubmed | 1.57e-12 | 12 | 123 | 6 | 9425112 | ||
| Pubmed | 1.57e-12 | 12 | 123 | 6 | 8656058 | ||
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 1.57e-12 | 12 | 123 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 1.57e-12 | 12 | 123 | 6 | 32016282 | |
| Pubmed | 1.57e-12 | 12 | 123 | 6 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 1.57e-12 | 12 | 123 | 6 | 26277892 | |
| Pubmed | 1.57e-12 | 12 | 123 | 6 | 6689487 | ||
| Interaction | IFNA5 interactions | 1.67e-07 | 22 | 120 | 5 | int:IFNA5 | |
| Interaction | LRRC31 interactions | 3.86e-06 | 205 | 120 | 9 | int:LRRC31 | |
| Interaction | DKK3 interactions | 5.66e-06 | 75 | 120 | 6 | int:DKK3 | |
| Interaction | CCDC8 interactions | MROH2A DYRK1A ELP1 MYO1B IQGAP1 MYO5C ITPR3 DNAH12 SLC12A2 GTF3C1 CLTC DYNC1H1 PCM1 CDC23 RPL18 | 8.33e-06 | 656 | 120 | 15 | int:CCDC8 |
| Interaction | TRIM37 interactions | MYH4 MYH13 CDKL3 MYO1B ACTR2 IQGAP1 MYO5C CDC7 ALMS1 CLTC LRP1 DIAPH3 PCM1 RPL18 | 2.34e-05 | 630 | 120 | 14 | int:TRIM37 |
| Interaction | FBXO42 interactions | 2.52e-05 | 259 | 120 | 9 | int:FBXO42 | |
| Interaction | BCAP31 interactions | MYH1 MYH4 MYH13 DYRK1A SMPD4 STT3B ITPR3 MGAT2 KARS1 SLC12A2 VKORC1L1 SYNE2 PDZD8 | 2.66e-05 | 554 | 120 | 13 | int:BCAP31 |
| Interaction | IFNA13 interactions | 3.28e-05 | 11 | 120 | 3 | int:IFNA13 | |
| Interaction | CYP2C9 interactions | 3.91e-05 | 105 | 120 | 6 | int:CYP2C9 | |
| Interaction | ISG15 interactions | DYRK1A MYO1B IFNA2 IFNA4 IFNA5 IFNA8 IFNA10 IQGAP1 MYO5C CLTC DYNC1H1 PCM1 | 3.95e-05 | 494 | 120 | 12 | int:ISG15 |
| Interaction | IFNA2 interactions | 4.36e-05 | 12 | 120 | 3 | int:IFNA2 | |
| Interaction | RSPH6A interactions | 4.83e-05 | 34 | 120 | 4 | int:RSPH6A | |
| Interaction | AVIL interactions | 6.78e-05 | 37 | 120 | 4 | int:AVIL | |
| Interaction | DERL1 interactions | ZFYVE27 SMPD4 DGKE STT3B ITPR3 SLC12A2 PIK3CA SYNE2 TMED8 TCF25 PDZD8 | 8.44e-05 | 453 | 120 | 11 | int:DERL1 |
| Interaction | IFNA4 interactions | 1.02e-04 | 41 | 120 | 4 | int:IFNA4 | |
| Interaction | FBXO32 interactions | 1.06e-04 | 386 | 120 | 10 | int:FBXO32 | |
| Interaction | IFNA1 interactions | 1.09e-04 | 16 | 120 | 3 | int:IFNA1 | |
| Interaction | EZR interactions | MYH13 SPTA1 ELP1 MYO1B IQGAP1 MYO5C SEPTIN8 KARS1 SLC12A2 TBC1D10A PDZD8 DIAPH3 | 1.16e-04 | 553 | 120 | 12 | int:EZR |
| Interaction | RAB11A interactions | SMPD4 STT3B MYO5C ITPR3 KAT2B KARS1 SLC12A2 SYNE2 CLTC PARVA LRP1 LRP2 PDZD8 DIAPH3 BZW1 | 1.24e-04 | 830 | 120 | 15 | int:RAB11A |
| Interaction | LMBR1L interactions | ELP1 DGKE STT3B IQGAP1 ITPR3 MGAT2 KARS1 SLC12A2 COG1 VKORC1L1 CLTC TCF25 BZW1 DYNC1H1 CDC23 SYMPK | 1.55e-04 | 946 | 120 | 16 | int:LMBR1L |
| Interaction | OTULINL interactions | SMPD4 DGKE STT3B ITPR3 AREL1 SLC12A2 VKORC1L1 SYNE2 TMED8 PDZD8 | 1.57e-04 | 405 | 120 | 10 | int:OTULINL |
| Interaction | CLEC4D interactions | 1.71e-04 | 261 | 120 | 8 | int:CLEC4D | |
| Cytoband | 9p22 | 3.85e-13 | 25 | 123 | 7 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 4.84e-08 | 124 | 123 | 7 | chr9p21 | |
| Cytoband | 5q31 | 2.70e-04 | 115 | 123 | 4 | 5q31 | |
| GeneFamily | Interferons | 1.02e-10 | 32 | 83 | 7 | 598 | |
| GeneFamily | Myosin heavy chains | 4.08e-05 | 15 | 83 | 3 | 1098 | |
| GeneFamily | Myosins, class I | 5.73e-04 | 8 | 83 | 2 | 1097 | |
| GeneFamily | Low density lipoprotein receptors | 1.57e-03 | 13 | 83 | 2 | 634 | |
| GeneFamily | Dyneins, axonemal | 2.71e-03 | 17 | 83 | 2 | 536 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 3.91e-09 | 29 | 122 | 6 | MM586 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.58e-08 | 39 | 122 | 6 | M41095 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | GABRP IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 BZW1 CDC23 | 5.56e-08 | 210 | 122 | 10 | MM751 |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 9.54e-08 | 80 | 122 | 7 | MM1229 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 1.45e-07 | 85 | 122 | 7 | MM684 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 1.50e-07 | 27 | 122 | 5 | M40935 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 1.71e-07 | 87 | 122 | 7 | MM652 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 2.04e-06 | 80 | 122 | 6 | MM646 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 2.76e-06 | 131 | 122 | 7 | MM1127 | |
| Coexpression | PTEN_DN.V1_UP | 2.73e-05 | 186 | 122 | 7 | M2787 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | SPTA1 LAMC2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA8 IFNA10 IFNA17 CDC7 ALMS1 | 9.22e-05 | 584 | 122 | 11 | MM1080 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-06 | 200 | 123 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-06 | 160 | 123 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 182 | 123 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 190 | 123 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 191 | 123 | 6 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 191 | 123 | 6 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.57e-05 | 192 | 123 | 6 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 193 | 123 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-05 | 193 | 123 | 6 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 193 | 123 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 194 | 123 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.66e-05 | 194 | 123 | 6 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-05 | 115 | 123 | 5 | 36cbb8666b33199b7552879922789bc227525b7b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.70e-05 | 115 | 123 | 5 | 6f92e45cbe9924ade10cb8a41884b0202070ab31 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 123 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 123 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-05 | 197 | 123 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-05 | 197 | 123 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 1.87e-05 | 198 | 123 | 6 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 198 | 123 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 199 | 123 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 199 | 123 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 199 | 123 | 6 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 1.97e-05 | 200 | 123 | 6 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.46e-05 | 152 | 123 | 5 | 5ce8920aedd39a4daf7082153b5e213707c14227 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type | 7.76e-05 | 158 | 123 | 5 | c4b0af25608cee3d0d2b0193f5ff45d9dc87078b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 169 | 123 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 169 | 123 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 1.09e-04 | 170 | 123 | 5 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 170 | 123 | 5 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 1.25e-04 | 175 | 123 | 5 | 2e048bf7961c3d86b6e12a1ebae3b3f2359af457 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 175 | 123 | 5 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.32e-04 | 177 | 123 | 5 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 177 | 123 | 5 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 177 | 123 | 5 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 177 | 123 | 5 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 177 | 123 | 5 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 179 | 123 | 5 | 7aa4137f672dadb3be92009cde6e0ea60a15372d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 181 | 123 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 182 | 123 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 1.54e-04 | 183 | 123 | 5 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.54e-04 | 183 | 123 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 184 | 123 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.58e-04 | 184 | 123 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 184 | 123 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 186 | 123 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 186 | 123 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 123 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 123 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 123 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 1.71e-04 | 187 | 123 | 5 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.75e-04 | 188 | 123 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.75e-04 | 188 | 123 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.75e-04 | 188 | 123 | 5 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-04 | 188 | 123 | 5 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.75e-04 | 188 | 123 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-04 | 188 | 123 | 5 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 190 | 123 | 5 | dc20d323cee2741e39fba597263d6418ae0eadaf | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 190 | 123 | 5 | ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 191 | 123 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.88e-04 | 191 | 123 | 5 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 191 | 123 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 191 | 123 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 191 | 123 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.93e-04 | 192 | 123 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 193 | 123 | 5 | 1fdfe08b0c82248545c29b504ac259b093fde29b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 193 | 123 | 5 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 193 | 123 | 5 | 5f90e3e526032d82d9dc7e0813fe79ca28dc0719 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 193 | 123 | 5 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.98e-04 | 193 | 123 | 5 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 193 | 123 | 5 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 194 | 123 | 5 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PND01-Epithelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 194 | 123 | 5 | d21db5e942966ed44bc78ff50130a201fc627074 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 195 | 123 | 5 | 43164511f32e4591cb5399182fbac0b911716233 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 195 | 123 | 5 | 9337111d75a487abc02969337718c30b1fe81379 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.12e-04 | 196 | 123 | 5 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 2.12e-04 | 196 | 123 | 5 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.12e-04 | 196 | 123 | 5 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-04 | 196 | 123 | 5 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.12e-04 | 196 | 123 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.12e-04 | 196 | 123 | 5 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.12e-04 | 196 | 123 | 5 | 37a5f9f3988778655580bd0383811bb4930c1551 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-04 | 197 | 123 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.23e-04 | 198 | 123 | 5 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Caecum-B_cell-B_cell_cycling|Caecum / Region, Cell class and subclass | 2.23e-04 | 198 | 123 | 5 | 61294fe99a5641ad359796022c3d038470076b3c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.23e-04 | 198 | 123 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.23e-04 | 198 | 123 | 5 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.23e-04 | 198 | 123 | 5 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.23e-04 | 198 | 123 | 5 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.23e-04 | 198 | 123 | 5 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.23e-04 | 198 | 123 | 5 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-04 | 198 | 123 | 5 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | Caecum-(2)_B_cell-(24)_B_cell_cycling|Caecum / shred on region, Cell_type, and subtype | 2.23e-04 | 198 | 123 | 5 | 568d47770cd20c6569ca84ea1eafde367642d68b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.28e-04 | 199 | 123 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-04 | 199 | 123 | 5 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.28e-04 | 199 | 123 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.28e-04 | 199 | 123 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| Drug | gunacin | 6.37e-11 | 14 | 123 | 6 | CID000198547 | |
| Drug | Yfrkd | 8.83e-11 | 7 | 123 | 5 | CID000129984 | |
| Drug | pppA2'-5'A2'-5'A | 1.06e-10 | 15 | 123 | 6 | CID000125229 | |
| Drug | 1hiv | 2.34e-10 | 8 | 123 | 5 | CID005479205 | |
| Drug | Chebi:36708 | 2.34e-10 | 8 | 123 | 5 | CID011966289 | |
| Drug | CHEMBL466993 | 3.40e-10 | 32 | 123 | 7 | CID005320808 | |
| Drug | p203 | 3.87e-10 | 18 | 123 | 6 | CID000019228 | |
| Drug | podophyllin | 3.87e-10 | 18 | 123 | 6 | CID011979494 | |
| Drug | Nyco | 3.87e-10 | 18 | 123 | 6 | CID000071618 | |
| Drug | AC1L9FQV | 6.13e-10 | 82 | 123 | 9 | CID000444118 | |
| Drug | pipobroman | 1.05e-09 | 10 | 123 | 5 | CID000004842 | |
| Drug | formosanin C | 1.53e-09 | 22 | 123 | 6 | CID000073597 | |
| Drug | flesinoxan | 1.91e-09 | 11 | 123 | 5 | CID000057347 | |
| Drug | Hiltonol | 2.06e-09 | 23 | 123 | 6 | CID000431963 | |
| Drug | AC1L1ZCT | 2.73e-09 | 24 | 123 | 6 | CID000038235 | |
| Drug | cycloferon | 2.73e-09 | 24 | 123 | 6 | CID000038072 | |
| Drug | Murabutida | 3.10e-09 | 43 | 123 | 7 | CID005362018 | |
| Drug | hycanthone | 3.58e-09 | 25 | 123 | 6 | CID000003634 | |
| Drug | ABMP | 4.63e-09 | 26 | 123 | 6 | CID000080567 | |
| Drug | R 842 | 5.27e-09 | 13 | 123 | 5 | CID000130714 | |
| Drug | inosiplex | 5.93e-09 | 27 | 123 | 6 | CID000037510 | |
| Drug | nocodazole | MYH1 MYH4 CLTCL1 MYH13 POLD1 KMT2E IQGAP1 MYO5C ITPR3 DOCK5 COG1 CLTC PARVA DYNC1H1 PCM1 CDC23 | 6.50e-09 | 477 | 123 | 16 | CID000004122 |
| Drug | Lanicemine | 8.16e-09 | 14 | 123 | 5 | CID003038485 | |
| Drug | NM 108 | 9.43e-09 | 29 | 123 | 6 | CID000500901 | |
| Drug | penciclovir | 1.17e-08 | 30 | 123 | 6 | CID000004725 | |
| Drug | poly rI:rC | 1.17e-08 | 30 | 123 | 6 | CID011979660 | |
| Drug | YNK01 | 2.49e-08 | 17 | 123 | 5 | CID000084071 | |
| Drug | carprofen | 2.61e-08 | 34 | 123 | 6 | CID000002581 | |
| Drug | purealin | 2.70e-08 | 58 | 123 | 7 | CID006419303 | |
| Drug | Lps2 | 2.70e-08 | 58 | 123 | 7 | CID000454710 | |
| Drug | tilorone | 3.14e-08 | 35 | 123 | 6 | CID000005475 | |
| Drug | pyran | 4.46e-08 | 37 | 123 | 6 | CID000033703 | |
| Drug | amantadine | 4.73e-08 | 95 | 123 | 8 | CID000002130 | |
| Drug | anagrelide | 5.27e-08 | 38 | 123 | 6 | CID000002182 | |
| Drug | Ciluprevir [USAN] | 6.16e-08 | 20 | 123 | 5 | CID006450803 | |
| Drug | val-mCyd | 6.16e-08 | 20 | 123 | 5 | CID006918726 | |
| Drug | isofagomine lactam | 6.20e-08 | 39 | 123 | 6 | CID000448980 | |
| Drug | copolymer 1 | 6.76e-08 | 66 | 123 | 7 | CID003081884 | |
| Drug | L DO | 8.05e-08 | 21 | 123 | 5 | CID000097725 | |
| Drug | 1 ind | 9.84e-08 | 42 | 123 | 6 | CID003037877 | |
| Drug | Sesquimustard | 1.14e-07 | 43 | 123 | 6 | CID000019092 | |
| Drug | NSC339663 | MYH1 MYH4 CLTCL1 MYH13 MYO1B MYO5C SLC12A2 PIK3CA SYNE2 CLTC MYO15A | 1.17e-07 | 250 | 123 | 11 | CID000003892 |
| Drug | 2',3'-dideoxycytidine diphosphate | 1.51e-07 | 74 | 123 | 7 | CID000128494 | |
| Drug | AC1L9AL3 | 1.73e-07 | 46 | 123 | 6 | CID000441122 | |
| Drug | entecavir | 1.97e-07 | 47 | 123 | 6 | CID000153941 | |
| Drug | LB80380 | 2.07e-07 | 25 | 123 | 5 | CID006480442 | |
| Drug | ridostin | 2.25e-07 | 116 | 123 | 8 | CID011979623 | |
| Drug | adefovir dipivoxil | 2.54e-07 | 49 | 123 | 6 | CID000060871 | |
| Drug | DTIC | 2.82e-07 | 81 | 123 | 7 | CID005281007 | |
| Drug | VX-497 | 3.11e-07 | 27 | 123 | 5 | CID000153241 | |
| Drug | formycin triphosphate | 3.25e-07 | 51 | 123 | 6 | CID000122274 | |
| Drug | trifluorothymidine | 3.25e-07 | 51 | 123 | 6 | CID000006256 | |
| Drug | famciclovir | 3.65e-07 | 52 | 123 | 6 | CID000003324 | |
| Drug | bropirimine | 3.65e-07 | 52 | 123 | 6 | CID000065457 | |
| Drug | acyclovir | 3.76e-07 | 124 | 123 | 8 | CID000002022 | |
| Drug | AC1NRD2B | 3.77e-07 | 28 | 123 | 5 | CID005289317 | |
| Drug | Ampligen | 4.10e-07 | 53 | 123 | 6 | CID000038077 | |
| Drug | DZNep | 5.42e-07 | 30 | 123 | 5 | CID000073087 | |
| Drug | AC1O52EF | 5.58e-07 | 13 | 123 | 4 | CID006450817 | |
| Drug | m IU | 5.72e-07 | 56 | 123 | 6 | CID006852123 | |
| Drug | imiquimod | 6.07e-07 | 132 | 123 | 8 | CID000057469 | |
| Drug | barium iodide | 6.13e-07 | 4 | 123 | 3 | CID000083684 | |
| Drug | AC1L1IZ2 | MYH1 MYH4 MYH13 MYO1B MCCC1 STT3B MYO5C ADORA3 GTF3C1 MYO15A DYNC1H1 | 8.21e-07 | 304 | 123 | 11 | CID000004795 |
| Drug | AC1L1U53 | 8.67e-07 | 60 | 123 | 6 | CID000060907 | |
| Drug | lobucavir | 1.21e-06 | 35 | 123 | 5 | CID000060786 | |
| Drug | AC1L1HZP | 1.28e-06 | 64 | 123 | 6 | CID000004361 | |
| Drug | adefovir | 1.28e-06 | 64 | 123 | 6 | CID000060172 | |
| Drug | imidazoquinoline | 1.28e-06 | 101 | 123 | 7 | CID005351568 | |
| Drug | 5H-purin-2-amine | 1.37e-06 | 102 | 123 | 7 | CID000409844 | |
| Drug | MCNU | 1.40e-06 | 36 | 123 | 5 | CID000071741 | |
| Drug | A809128 | 1.40e-06 | 36 | 123 | 5 | CID003392279 | |
| Drug | B132 | 1.53e-06 | 5 | 123 | 3 | CID002734031 | |
| Drug | AC1O51IP | 1.53e-06 | 66 | 123 | 6 | CID006450363 | |
| Drug | FMAU | 1.61e-06 | 37 | 123 | 5 | CID000072327 | |
| Drug | vindesine | 1.83e-06 | 68 | 123 | 6 | CID000040839 | |
| Drug | fotemustine | 1.85e-06 | 38 | 123 | 5 | CID000104799 | |
| Drug | cycloleucine | 2.00e-06 | 69 | 123 | 6 | CID000002901 | |
| Drug | Leucine enkephalin | 2.14e-06 | 109 | 123 | 7 | CID000003903 | |
| Drug | NSC105014 | 2.27e-06 | 110 | 123 | 7 | CID000001546 | |
| Drug | 9-cis-acitretin | 2.36e-06 | 71 | 123 | 6 | CID000041317 | |
| Drug | N6-methyl-(R)-roscovitine | 2.36e-06 | 71 | 123 | 6 | CID005289296 | |
| Drug | arabinosylthymine | 2.78e-06 | 73 | 123 | 6 | CID000065049 | |
| Drug | dipyridamole | 2.84e-06 | 162 | 123 | 8 | CID000003108 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.84e-06 | 162 | 123 | 8 | CID000072363 | |
| Drug | NSC-218321 | 2.88e-06 | 114 | 123 | 7 | CID000004739 | |
| Drug | HCV-371 | 3.04e-06 | 6 | 123 | 3 | CID003013096 | |
| Drug | resiquimod | 3.06e-06 | 115 | 123 | 7 | CID000159603 | |
| Drug | blebbistatin | 3.24e-06 | 116 | 123 | 7 | CID003476986 | |
| Drug | B0683 | 3.43e-06 | 117 | 123 | 7 | CID006398969 | |
| Drug | NSC 312887 | 3.46e-06 | 43 | 123 | 5 | CID000003368 | |
| Drug | 2',3'-dideoxycytidine (ddC | 3.53e-06 | 76 | 123 | 6 | CID000005718 | |
| Drug | AC1MMF4B | 3.81e-06 | 77 | 123 | 6 | CID003260010 | |
| Drug | Zinetac | 4.77e-06 | 80 | 123 | 6 | CID000005039 | |
| Drug | D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 | 6.68e-06 | 49 | 123 | 5 | CID000365716 | |
| Drug | glycrrhizin | 7.26e-06 | 86 | 123 | 6 | CID000003495 | |
| Drug | 2'-deoxy-3'-thiacytidine | 7.77e-06 | 87 | 123 | 6 | CID000003877 | |
| Drug | AC1L40MO | 8.01e-06 | 133 | 123 | 7 | CID000099067 | |
| Drug | AC1LAD6M | 8.45e-06 | 8 | 123 | 3 | CID000511663 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 8.45e-06 | 8 | 123 | 3 | CID010011375 | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.20e-05 | 197 | 123 | 8 | 5482_DN | |
| Disease | obesity (implicated_via_orthology) | 3.10e-06 | 215 | 121 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 7.90e-06 | 10 | 121 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.44e-05 | 12 | 121 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.44e-05 | 12 | 121 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.87e-05 | 13 | 121 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.95e-05 | 15 | 121 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Schizophrenia | HTR2C ADARB1 ACTR2 SEMA3D SLC12A2 PIK3CA TLR4 LRP1 LRP2 KCNQ3 ULK4 TAAR1 PCM1 | 7.07e-05 | 883 | 121 | 13 | C0036341 |
| Disease | melanoma | 7.62e-05 | 248 | 121 | 7 | C0025202 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.11e-04 | 71 | 121 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.18e-04 | 152 | 121 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | GABRP MYH1 ETS2 MED14 ELP1 DGKE IFNA2 EPG5 LIPE PIK3CA SYNE2 PRKAA2 ZFYVE26 | 4.75e-04 | 1074 | 121 | 13 | C0006142 |
| Disease | Colorectal Carcinoma | POLD1 MYO1B IFNA2 ADORA3 PIK3CA TLR4 LRP1 LRP2 JAKMIP1 CCDC93 | 6.45e-04 | 702 | 121 | 10 | C0009402 |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 7.50e-04 | 99 | 121 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Acute kidney injury | 8.08e-04 | 101 | 121 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 8.08e-04 | 101 | 121 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 8.08e-04 | 101 | 121 | 4 | C0022660 | |
| Disease | Weight Gain | 8.39e-04 | 102 | 121 | 4 | C0043094 | |
| Disease | myopathy (implicated_via_orthology) | 1.02e-03 | 48 | 121 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | coronary artery disease | PDE1A CLTCL1 DNAH10 NBEAL1 NT5C1B ACTR2 TWIST1 EPG5 DOCK5 LRP1 JAKMIP1 GPSM1 PMFBP1 | 1.26e-03 | 1194 | 121 | 13 | EFO_0001645 |
| Disease | Polydactyly | 1.40e-03 | 117 | 121 | 4 | C0152427 | |
| Disease | Malformations of Cortical Development | 1.47e-03 | 14 | 121 | 2 | C1955869 | |
| Disease | Adenocarcinoma Of Esophagus | 1.47e-03 | 14 | 121 | 2 | C0279628 | |
| Disease | phoneme awareness | 1.47e-03 | 14 | 121 | 2 | EFO_0021812 | |
| Disease | Cortical Dysplasia | 1.47e-03 | 14 | 121 | 2 | C0431380 | |
| Disease | Chronic Lymphocytic Leukemia | 1.51e-03 | 55 | 121 | 3 | C0023434 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.93e-03 | 16 | 121 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | amino acid measurement | 1.95e-03 | 678 | 121 | 9 | EFO_0005134 | |
| Disease | Renal Insufficiency | 2.18e-03 | 17 | 121 | 2 | C1565489 | |
| Disease | Global developmental delay | 2.23e-03 | 133 | 121 | 4 | C0557874 | |
| Disease | Ischemic stroke | 2.24e-03 | 324 | 121 | 6 | HP_0002140 | |
| Disease | Microcephaly | 2.66e-03 | 67 | 121 | 3 | C0025958 | |
| Disease | colorectal cancer, inflammatory bowel disease | 2.72e-03 | 19 | 121 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | Cardiomyopathies, Primary | 2.89e-03 | 69 | 121 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 2.89e-03 | 69 | 121 | 3 | C0036529 | |
| Disease | stroke | 2.97e-03 | 144 | 121 | 4 | EFO_0000712 | |
| Disease | Kidney Failure | 3.65e-03 | 22 | 121 | 2 | C0035078 | |
| Disease | unipolar depression, bipolar disorder | 3.96e-03 | 156 | 121 | 4 | EFO_0003761, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKALQYVNARLRDLY | 356 | Q96P26 | |
| YELLLNYSRCRKQLL | 291 | Q9HCE0 | |
| ALYFQRALKLNPRYL | 351 | Q9UJX2 | |
| LLRYYIHLQRINNLS | 2801 | Q96N23 | |
| TLRAAIRYIKYLQEL | 196 | Q7RTU5 | |
| LFRYFELLEKLQYNL | 496 | Q96P56 | |
| AQVFNKLIRRYKYLE | 111 | Q7L1Q6 | |
| IYLDIFYIIRNKLSL | 196 | P0DMS8 | |
| QLYLVDNRSYLLDFK | 456 | P54646 | |
| RLRKYLFQILRAIDY | 101 | Q8IVW4 | |
| KNLYFLYLIELRALS | 301 | Q86YB8 | |
| LVYTLFNKIYRRAFS | 366 | P28335 | |
| IKLYSSITNQQRRYL | 3806 | Q8TCU4 | |
| LRAYIRKQINNIFYR | 196 | Q13362 | |
| YSFAQFRYLQRLLLV | 846 | Q8TF62 | |
| LSYNLYDLLRNTNFR | 241 | Q13627 | |
| QFRQVLYYELLAIRE | 676 | Q9H9G7 | |
| LAEYFRLQYGERLLQ | 11 | Q96M95 | |
| LIRNDYFIRQQYFKL | 446 | Q9NSV4 | |
| RFLKLKYYSIILQSR | 1366 | Q8IZT6 | |
| RYLIKLLLLRGYAFN | 191 | P61160 | |
| NYASNQREEYLLLRL | 1011 | P46940 | |
| YALLLNQKYSDRLRE | 1141 | Q6ZS30 | |
| QFILNVRLDYRISYL | 976 | Q14573 | |
| LAVRKYFQRITLYLI | 141 | P01566 | |
| FRYVLDYLRDKQLAL | 106 | Q6ZWB6 | |
| NLTLRYRSLVYQLNF | 86 | Q10469 | |
| VYFYLFKLLRKSILQ | 186 | Q92831 | |
| LYQTRFLRQLVIYLC | 246 | Q5VYY2 | |
| NLKIRFERNLIYTYI | 1241 | Q9UKN7 | |
| YYKKTLQLSRQLRDQ | 271 | Q86YR5 | |
| LIFANRYYLRKLNLD | 3031 | Q07954 | |
| NAKYRRIQTLIYDAL | 101 | O43525 | |
| YRAEYINFLENLKIL | 1181 | Q5H9U9 | |
| QLLNTDYLRQRALYA | 1411 | Q15154 | |
| DYLRQRALYALQDIV | 1416 | Q15154 | |
| YYRLLTAQILDREKA | 401 | Q9Y5G4 | |
| YELFTRYDLINRFKI | 181 | P54750 | |
| FLTLLAQFFLLYRRQ | 16 | Q8NEN9 | |
| KRYVYRFVCDLQNLL | 436 | P15036 | |
| LTVRKYFQRITLYLT | 141 | P01569 | |
| LKILITFRISNYFKY | 1741 | Q6ZR08 | |
| AVLYLRRLNAVYLNS | 251 | Q8N8W4 | |
| LKKRRFYQLLDSVYS | 871 | Q8IZD2 | |
| EALRLVYKYNRLDII | 1091 | O95163 | |
| LTREYQALQRAYALL | 491 | Q96N16 | |
| RILYADFKQRYKVLN | 716 | P12882 | |
| LIFSNRYYLRNLTID | 3201 | P98164 | |
| RSLLRFLYTQLELYL | 401 | P78563 | |
| FSSRYYELLKQRQAL | 31 | Q8TE96 | |
| YEQYLDNLLVRFLLK | 641 | P42336 | |
| EYLEKALEYLRQIFR | 656 | Q9NXE4 | |
| IQYFLDRFYLSRISI | 151 | Q15119 | |
| IFSEVRVYNYRKLIL | 796 | O60244 | |
| TFYIRSYILNKDLLR | 526 | Q6ZMV5 | |
| YTYSQLQQILRSRLK | 681 | Q13415 | |
| RAELIQYQKRFIELY | 491 | Q567U6 | |
| RILLDNREYLALNVY | 176 | A0AVF1 | |
| KYLFRFIIQSRVLYL | 761 | Q9H7D0 | |
| VTQNRALQLLYDLRY | 801 | Q8WTW3 | |
| LYELLQYIKTQRRAL | 106 | Q9Y603 | |
| SNFLYNRRLKKYALV | 181 | O00311 | |
| KIFYLNLLAQYRLAS | 656 | O15033 | |
| AVRKYFQRITLYLKE | 141 | P01563 | |
| AALTKLRYSLRQYNI | 446 | Q96RQ3 | |
| PALKRYERLSYNFLQ | 396 | O00754 | |
| RLRQYASYEFVQRLL | 1376 | Q14204 | |
| LSYFEYRRLLRNLTA | 331 | Q13753 | |
| LAVRKYFQRITLYLT | 141 | P32881 | |
| LLRLYLDRVFKNYQT | 86 | Q9NYY1 | |
| LFSSRILNKAVYLFY | 396 | P52429 | |
| ILYNLVLRNLEERNY | 486 | Q5W0V3 | |
| RQQLYKLIISQLLYD | 11 | Q05048 | |
| LQEEYTRYLFALQLK | 131 | O94887 | |
| LYLLRLRAARAYLQA | 456 | Q8NFJ9 | |
| NFRLYLNTKLANPRY | 3521 | Q8IVF4 | |
| QVLLREYKLRSYTLN | 461 | P28340 | |
| KLYLLFAQHRYISRL | 216 | Q9HBV1 | |
| LAVRKYFQRITLYLT | 141 | P01571 | |
| FELRRNVLYFILETY | 236 | O00591 | |
| QLRALVYYAQRLLVT | 421 | Q05469 | |
| LAVRKYFQRITLYLT | 141 | P05013 | |
| YKLTNRREKFYQRDL | 481 | A6NES4 | |
| IASLERSLNLYRDKY | 171 | Q8TBY8 | |
| QRILYLQVLDYDRFS | 216 | O43581 | |
| YSRLREYLLTQDQLK | 926 | Q8N1G1 | |
| LLHIDKRREYLYQLQ | 731 | Q8TF05 | |
| KRREYLYQLQEFLVT | 736 | Q8TF05 | |
| RSYQNEIKRLYHQLI | 4636 | Q8WXH0 | |
| RYRQRYLDLILNDFV | 226 | Q15046 | |
| LYINLAAIYLKQRLR | 571 | Q8TF17 | |
| RILYADFKQRYKVLN | 716 | Q9Y623 | |
| LAVRKYFQRITLYLT | 141 | P05014 | |
| STLRVLYNLFTKYRN | 356 | Q9NVD7 | |
| LAESRLRYKDYIQIL | 706 | O95025 | |
| DLVLYLYRNNLQKYI | 786 | Q00610 | |
| DLVLYLYRNNLQRYI | 786 | P53675 | |
| VLLYQQFYILKSCLR | 556 | Q8IXR9 | |
| QDIYLRLLVKLYRFL | 21 | Q07020 | |
| LQAYAFLQYLRDRLT | 331 | Q8TCJ2 | |
| QKYNRLLLYRLDRSI | 56 | Q5T4T6 | |
| LYKTKTYRQIRLNEL | 1141 | P55011 | |
| RILYADFKQRYRILN | 716 | Q9UKX3 | |
| YLQEELKIRRSLFDY | 131 | Q92599 | |
| YRIYLIAKEQARLIS | 211 | Q96RJ0 | |
| RRLLQRYNEFLLAYE | 1076 | P02549 | |
| RKYKVLYNSQLLFRS | 306 | Q6ZUG5 | |
| YVLNFLLLIINYKRL | 146 | Q8N0U8 | |
| LLLIINYKRLVYLNE | 151 | Q8N0U8 | |
| FYYKIALFLKQRNRQ | 206 | Q9BXA5 | |
| REYVEKFALNYLQLL | 746 | Q92797 | |
| QRLTYLVNLLTRYKI | 1761 | Q9P2E3 | |
| DLFNLVLSYKRLEIY | 36 | Q5T4F4 | |
| QRYREYLQRQKLFDT | 31 | Q53H54 | |
| IRQQLLYKRRYIFSV | 951 | Q12789 | |
| QQDLFRVLKAYTLYR | 176 | Q9BXI6 | |
| QQVELYRLLSRNTYL | 781 | O00206 | |
| IQTLKLAARYIDFLY | 146 | Q15672 | |
| TRLRNQLLEAEYYQL | 2036 | Q68DK2 | |
| EKYNNLDLFRYLLNI | 1706 | O60293 | |
| LRARNYEYLIRLFQE | 391 | Q9BQ70 | |
| YLEAKRLLKEFQARY | 726 | Q6P2D8 | |
| LGRYIARKLNINYFD | 181 | Q2WGJ8 | |
| YLLKFDNSYSLLRNK | 301 | Q6PL24 | |
| KAFLVLLYILIYNRE | 751 | Q96C45 | |
| NKLKLERDFSRYNYL | 221 | O43795 | |
| NLRKRFSENLIYTYI | 31 | Q8N1T3 | |
| NLRIRFAESKLIYTY | 86 | Q9NQX4 |